Optiscan Imaging Ltd is a company known for its strong commitment to innovation and excellence in medical imaging. With a vision to improve patient outcomes, Optiscan prides itself on providing cutting-edge solutions for real-time cellular imaging. The company's corporate philosophy revolves around leveraging advanced technology to enhance diagnostic accuracy and enhance the effectiveness of medical procedures. Optiscan Imaging Ltd values integrity, collaboration, and a customer-centric approach, ensuring that their products and services meet the evolving needs of the medical community. By prioritizing research and development, Optiscan aims to revolutionize the field of medical imaging, while maintaining a steadfast dedication to quality and patient care.

Optiscan Imaging Ltd is primarily present in Australia.

Optiscan Imaging Ltd has achieved several significant milestones. The company successfully developed and patented a revolutionary confocal endomicroscopy technology, which enables real-time, high-resolution imaging of living tissue. Optiscan Imaging Ltd also received clearance from the U.S. Food and Drug Administration (FDA) for its confocal endomicroscopy system, facilitating its entry into the American market. Furthermore, the company collaborated with renowned medical institutions and researchers worldwide to conduct clinical studies and validate the efficacy of its imaging technology. Optiscan Imaging Ltd's relentless dedication to innovation and research has positioned it as a leader in the field of real-time tissue imaging.

Optiscan Imaging Ltd is a renowned company specializing in medical imaging technologies. Established in [year], Optiscan has achieved significant milestones in the field of diagnostic imaging. The company is known for its innovative optical imaging systems, such as confocal microscopy, which provide high-resolution cellular images for diagnostic purposes. Optiscan Imaging Ltd has a rich history of research and development, consistently striving to push the boundaries of medical imaging. With its advanced imaging solutions, Optiscan continues to contribute to the progression of healthcare.

The main competitors of Optiscan Imaging Ltd in the market include companies such as Carl Zeiss Meditec AG, NIDEK CO., LTD., and Topcon Corporation.

Optiscan Imaging Ltd is primarily active in the medical technology and healthcare industries.

The business model of Optiscan Imaging Ltd focuses on developing and commercializing advanced medical imaging technologies. The company specializes in the design and manufacture of confocal laser endomicroscopes, which are used in various medical applications. Optiscan Imaging aims to improve the diagnosis and treatment of diseases through their innovative imaging solutions. By leveraging their expertise in advanced imaging technologies, the company aims to provide healthcare professionals with high-quality and real-time cellular imaging during medical procedures. Optiscan Imaging Ltd's business model is centered around offering cutting-edge medical imaging technologies that deliver precise and detailed cellular imaging for improved patient outcomes.

P/E odnos Optiscan Imaging iznosi -25,80.

KUV kompanije Optiscan Imaging iznosi 135,31.

AlleAktien kvalitativni skor za Optiscan Imaging je 7/10.

Optiscan Imaging promet je 1,16 mil. AUD.

Dobit Optiscan Imaging je -6,06 mil. AUD.

Optiscan Imaging Ltd is a leading provider of high-quality microscope systems and components for scientific research, medical diagnostics, and industrial testing and quality assurance. The company was founded in Melbourne, Australia in 1994 and has since expanded its operations worldwide. Today, Optiscan Imaging is a global company that delivers innovative technologies and products to meet the needs of its customers in various industries.

Optiscan Imaging isplaćuje dividendu od 0 AUD raspoređenu preko isplata u toku godine.

Dividenda za Optiscan Imaging trenutno ne može biti izračunata ili kompanija ne isplaćuje dividendu.

ISIN od Optiscan Imaging je AU000000OIL4.

WKN od Optiscan Imaging je 932111.

Oznaka za praćenje akcija kompanije Optiscan Imaging je OIL.AX.

U poslednjih 12 meseci, Optiscan Imaging je isplatio dividendu u iznosu od . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, Optiscan Imaging će verovatno isplatiti dividendu od 0 AUD.

Dividendski prinos od Optiscan Imaging trenutno iznosi .

Optiscan Imaging isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Optiscan Imaging je isplaćivao dividendu svake godine u poslednjih 0 godina.

Za narednih 12 meseci očekuju se dividende u iznosu od 0 AUD. To odgovara dividendnom prinosu od 0 %.

Optiscan Imaging se svrstava u sektor 'Zdravlje'.

Da biste primili poslednju dividendu od Optiscan Imaging od 30. 9. 2024. u iznosu od 0 AUD, morali ste da imate akciju u depou pre Ex-dana 30. 9. 2024..

Isplata poslednje dividende izvršena je 30. 9. 2024..

U godini 2023 kompanija Optiscan Imaging je isplatila 0 AUD kao dividende.

Dividende od Optiscan Imaging se isplaćuju u AUD.